Application of serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) as biomarkers in the clinical management of multiple sclerosis (NeuroFilMS): a protocol for an observational cohort study.
Rust R, Samadzadeh S, Röper A-L, Stahmann A, Schindler P, Neumaier M, Rausch H-W, Schirmer L, Kuhle J, Tumani H, et al.
